GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

Trending Topics in Gastroenterology

Explore current gastroenterology questions, clinical answers, and emerging research by topic.

71

The synergy of carvedilol and simvastatin

The synergy between carvedilol and simvastatin represents a promising multifaceted approach to managing portal hypertension in patients with cirrhosis, particularly those who exhibit poor responses to traditional non-selective...

72

DILI control compounds list: An analysis of FAERS data

The analysis of the DILI (drug-induced liver injury) control compounds list using FAERS (FDA Adverse Event Reporting System) data aimed to validate the consensus-driven list of DILI-positive and...

73

Nucleos(t)ide analogue cessation and HBV flare

Nucleos(t)ide analogue (NA) cessation in chronic hepatitis B (CHB) infection is a complex process that can lead to hepatitis flares, characterized by a rise in alanine aminotransferase (ALT)...

74

Paediatric acute hepatitis of unknown origin (PAHUO)

Overview: Paediatric Acute Hepatitis of Unknown Origin (PAHUO) refers to cases of acute liver inflammation in children where no known cause—such as viral hepatitis (A, B, C, D,...

75

Sequential therapy with antisense oligonucleotide and immune modulator as HBV cure

Sequential therapy combining antisense oligonucleotides (ASOs) and immune modulators represents a promising strategy to achieve a functional cure for chronic hepatitis B virus (HBV). Below, I will explain...

76

MetALD: Position statement by an expert panel

The expert position statement on Metabolic dysfunction- and Alcohol-related Liver Disease (MetALD) provides a comprehensive overview of the definition, diagnosis, and management of MetALD within the newly updated...

77

EASL-ERN Clinical Practice Guidelines on Wilson’s Disease

As of October 2023, the European Association for the Study of the Liver (EASL) and the European Reference Network (ERN) for Rare Liver Diseases have provided Clinical Practice...

78

Impact of sarcopenia and frailty on decompensated liver disease

Sarcopenia and frailty are both clinical conditions that can significantly influence the progression and outcomes of liver diseases, including decompensated cirrhosis. Below is a detailed explanation of each...

79

Type-1, -2, and -3 inflammation and severity of decompensated cirrhosis

Type-1, Type-2, and Type-3 inflammation are classifications of immune responses that represent distinct biological pathways activated in response to different types of stimuli. These inflammation types play critical...

80

Systemic Inflammatory Index, TIPS and long term mortality

Systemic Inflammatory Index (SII): The Systemic Inflammatory Index (SII) is a biomarker that reflects systemic inflammation by combining platelet, neutrophil, and lymphocyte counts into a single formula. It...

Previous
178910
Next
GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer